Altogether, we find no general association of the TOPBP1 Arg309Cys variant with breast cancer risk, and the direction of the marginally significant association with bilateral disease in our study is in conflict with the original data.
← all excerpts
TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study.
1
—
—